Sponsor

UNITAID

Clinical research sponsor

Published trials22
Recruiting shown1
Roles1
SourceClinicalTrials.gov

Clinical trials

22 shown
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income CountriesNCT06395129 · collaborator · 2024-09-13
RECRUITING
Pharmacokinetics and Safety of DolutegravIr in NeonateNCT05590325 · collaborator · 2022-09-12
UNKNOWN
CHARACTERISE - A Cross-sectional, Observational Study to Characterise the Transition to Dolutegravir-based Regimens in South Africa in Terms of the Emergence of Obesity, Viral Re-suppression and Integration Into Routine Programme CareNCT05502692 · collaborator · 2022-07-12
COMPLETED
INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and KenyaNCT05382130 · collaborator · 2022-05-17
COMPLETED
Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and KenyaNCT05498727 · collaborator · 2022-05-02
COMPLETED
Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB TrialNCT04494516 · collaborator · 2021-06-04
COMPLETED
Inflammation and Co-Infections in D²EFTNCT04183738 · collaborator · 2021-02-01
WITHDRAWN
COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited SettingsNCT04371835 · collaborator · 2020-08-12
COMPLETED
Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children (TB-Speed HIV)NCT04121026 · collaborator · 2019-10-02
COMPLETED
Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric FormulationNCT03836833 · collaborator · 2019-06-04
UNKNOWN
A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])NCT03541382 · collaborator · 2018-10-08
COMPLETED
Secondary Distribution of HIV Self-tests Through Antenatal Care Clinic Attendees and Index ClientsNCT03705611 · collaborator · 2018-09-12
UNKNOWN
Dolutegravir in Pregnant HIV Mothers and Their NeonatesNCT03249181 · collaborator · 2018-01-22
COMPLETED
Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In ZimbabweNCT04206241 · collaborator · 2018-01-01
COMPLETED
Dolutegravir and Darunavir Evaluation in Adults Failing TherapyNCT03017872 · collaborator · 2017-11-23
UNKNOWN
Impact of Point-of-Care EID for HIV-Exposed InfantsNCT03824067 · collaborator · 2017-08-01
COMPLETED
Evaluating the Feasibility of Point of Care Birth Testing in EswatiniNCT04206878 · collaborator · 2017-06-01
COMPLETED
Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited SettingsNCT02777229 · collaborator · 2016-07-01
COMPLETED
HIV Self-Testing Africa ZambiaNCT02793804 · collaborator · 2016-06-01
COMPLETED
HIV Self-Testing Africa (STAR) Malawi: General PopulationNCT02718274 · collaborator · 2016-04-01
COMPLETED
Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally (LIVING Study)NCT02346487 · collaborator · 2015-09-01
COMPLETED
Early Infant Diagnosis Point of Care PilotNCT02634450 · collaborator · 2015-09-01
COMPLETED

Sponsor roles

collaborator22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.